Tirzepatide
A next-generation dual-action peptide for comprehensive metabolic support.
What It Is
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist. Unlike single-pathway medications, Tirzepatide activates two key metabolic pathways simultaneously—glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). This dual mechanism provides broader metabolic support than traditional single-target therapies, making it one of the most effective peptides available for weight management and metabolic optimization.
Who It's For
What It Does
How It Works
Tirzepatide works by mimicking two naturally occurring hormones that your body releases after eating:
Administered via once-weekly subcutaneous injection, Tirzepatide provides steady metabolic support throughout the week without daily dosing requirements.
What to Expect
Short Term (Weeks 1-4)
Long Term (Months 2-6+)
Best Paired With
Ready to Learn More About Tirzepatide?
Schedule a consultation to discuss whether Tirzepatide is right for your health goals.
All therapies are provided only after appropriate consultation and eligibility screening. Peptide therapy should be administered under professional medical supervision. Individual results vary.